middle.news
Neurizon Secures Global Trademark Protection Ahead of Key Drug Trials
9:56am on Tuesday 20th of January, 2026 AEDT
•
Biotechnology
Read Story
Neurizon Secures Global Trademark Protection Ahead of Key Drug Trials
9:56am on Tuesday 20th of January, 2026 AEDT
Key Points
Registered trademark protection secured in US, EU, UK, Australia, and Japan
Trademark covers pharmaceutical R&D and clinical trial services (Class 42)
Supports global brand consistency and intellectual property framework
Complements patent portfolio for lead asset NUZ-001
Read Story
middle.
Tap to Read
Tap the card to read the full analysis
about
Neurizon Therapeutics (ASX:NUZ)
OPEN ARTICLE